We know that your time with your movement disorder specialist can be limited, and we want to provide you with as much content from our local experts as possible. To do this, the PAA is excited to announce a partnership with the UAB Movement Disorders Clinic by launching a quarterly webinar series. This series will be led by UAB’s Movement Disorder Specialists and Practitioners.
We kick things off on June 6th with UAB Chairman for the Department of Neurology and Movement Disorders Clinic, Dr. David Standaert, as he provides the latest update on research, treatments, and therapies for Parkinson’s disease. Learn about open clinical trials and advancements on the brink of approval to incorporate into your treatment paths for the future. This webinar is FREE, but does require registration.
Dr. Standaert was named the John N. Whitaker Professor & Chair of Neurology in 2012. Prior to that, he was appointed the John T. and Juanelle D. Strain Endowed Chair by the Board of Trustees of the University of Alabama system, which he held for five years. He received his M.D. and Ph.D. degrees from Washington University in St. Louis in medicine at Jewish Hospital of St. Louis in 1989 and a three-year neurology residency in 1992 at the University of Pennsylvania. He completed a three-year research and clinical fellowship in neurology (movement disorders) at Harvard Medical School Massachusetts General Hospital in 1992.
Dr. Standaert is licensed to practice medicine in the states of Massachusetts and Alabama and was board certified in 1992 by the American Board of Psychiatry and Neurology. Dr. Standaert’s clinical teaching has consisted of: serving as an attending physician on the MGH Neurology inpatient service, one month each year; teaching residents, fellows and medical students in the Movement Disorders clinic on a weekly basis; and teaching in Resident’s clinic about once a month. Classroom teaching has consisted of serving as member of the Core Faculty for Harvard Health Sciences Technology Pharmacology Course (HST150) and lecturer for the Harvard Medical School Human Neuroscience and Behavior course.
Dr. Standaert serves as Director of the Center for Neurodegeneration and Experimental Therapeutics, Director of the Division of Movement Disorders in the Department of Neurology, Director of the American Parkinson Disease Association (APDA) Advanced Center for Parkinson Research, and Director of the UAB Bachmann-Strauss Dystonia and Parkinson’s Disease Center of Excellence. He sees many patients in a weekly clinic and oversees many clinical trials for new treatments in Parkinson’s disease.
This webinar will be livestreamed over zoom. You will be provided with the zoom link one day prior to the presentation on Monday, June 5th. You must enter your email address in order to be provided with the zoom link to access the presentation. We will be recording this webinar and distributing a link to the recording after the session within a week. There will be time for questions, so you are encouraged to attend the presentation’s livestream.